1. Home
  2. CYTK vs SPXC Comparison

CYTK vs SPXC Comparison

Compare CYTK & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.51

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo SPX Technologies Inc.

SPXC

SPX Technologies Inc.

HOLD

Current Price

$206.18

Market Cap

9.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
SPXC
Founded
1997
1912
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
9.1B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CYTK
SPXC
Price
$62.51
$206.18
Analyst Decision
Strong Buy
Buy
Analyst Count
16
7
Target Price
$78.94
$214.14
AVG Volume (30 Days)
1.7M
728.1K
Earning Date
11-05-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.00
EPS
N/A
4.69
Revenue
$87,211,000.00
$2,161,500,000.00
Revenue This Year
$361.33
$16.08
Revenue Next Year
$65.14
$8.42
P/E Ratio
N/A
$43.24
Revenue Growth
2609.26
12.60
52 Week Low
$29.31
$115.00
52 Week High
$69.33
$233.71

Technical Indicators

Market Signals
Indicator
CYTK
SPXC
Relative Strength Index (RSI) 49.62 44.19
Support Level $59.37 $207.04
Resistance Level $63.80 $226.31
Average True Range (ATR) 2.56 7.57
MACD -0.44 -1.13
Stochastic Oscillator 42.46 9.88

Price Performance

Historical Comparison
CYTK
SPXC

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.

Share on Social Networks: